NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021

NEXT STORY
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
PREV STORY
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biofidelity raises $12m in Series A financing

author_avatar
NASDAQ Market News

Philips highlights AI-powered solutions focus to realize precision diagnosis at RSNA 2019

author_avatar
NASDAQ Market News

Cytovia Therapeutics, Inc appoints Dr. Wei Li as Chief Scientific Officer to accelerate the development of iPSC CAR-NK Cell Therapy for Cancer

author_avatar
NASDAQ Market News